Search

Your search keyword '"van Vulpen, Lize F D"' showing total 151 results

Search Constraints

Start Over You searched for: Author "van Vulpen, Lize F D" Remove constraint Author: "van Vulpen, Lize F D"
151 results on '"van Vulpen, Lize F D"'

Search Results

2. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A

3. Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease

4. Limited value of testing for factor XIII and α2‐antiplasmin deficiency in patients with a bleeding disorder of unknown cause.

6. Towards Personalized Treatment in Haemophilia: The Role of Genetic Factors in Iron and Heme Control to Identify Patients at Risk for Haemophilic Arthropathy.

7. Subclinical synovial proliferation in patients with severe haemophilia A: The value of ultrasound screening and biochemical markers

8. Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study

10. Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion

11. Clotting factor activity levels and bleeding risk in people with haemophilia playing sports

13. Structural changes after ankle joint distraction in haemophilic arthropathy: an explorative study investigating biochemical markers and 3D joint space width

14. Pre-operative synovial hyperaemia in haemophilia patients undergoing total knee replacement and the effects of genicular artery embolization: A retrospective cohort study

15. Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy

16. Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study

17. Structural changes after ankle joint distraction in haemophilic arthropathy: an explorative study investigating biochemical markers and 3D joint space width

18. Magnetic resonance imaging evidence for subclinical joint bleeding in a Dutch population of people with severe hemophilia on prophylaxis

19. Monitoring recovery of joints after bleeding: Physical examination and ultrasound are complementary

20. Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients

21. The detrimental effects of iron to the joint; aggravation by inflammation

22. In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype

25. Ankle joint distraction is a promising alternative treatment for patients with severe haemophilic ankle arthropathy

27. Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study

28. Validation of the pedHALshort and HALshort in Dutch children and adults with haemophilia

29. Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study

31. Liver‐related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders.

32. Validation of the pedHALshort and HALshort in Dutch children and adults with haemophilia.

33. Additional file 1 of Detecting low blood concentrations in joints using T1 and T2 mapping at 1.5, 3, and 7 T: an in vitro study

35. Hepatitis C virus in hemophilia: Health-related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study

36. Generic PROMIS item banks in adults with hemophilia for patient-reported outcome assessment: Feasibility, measurement properties, and relevance

37. Detecting low blood concentrations in joints using T1 and T2 mapping at 1.5, 3, and 7 T: an in vitro study

38. Validation of PROMIS Profile-29 in adults with hemophilia in the Netherlands

39. On-demand treatment with the iron chelator deferasirox is ineffective in preventing blood-induced joint damage in haemophilic mice

40. Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972-2019

41. Mortality, life expectancy and causes of death of persons with hemophilia in the Netherlands 2001-2018

42. Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study

43. Synovitis and synovectomy in haemophilia

44. Real-Life Pharmacokinetics of rFVIII-Fc and rFIX-Fc

47. Models of arthropathy: what can we learn from them to improve patient care?

48. An update on the ‘danger theory’ in inhibitor development in hemophilia A

49. Severe Wound Healing Impairment in a Patient with Dysfibrinogenaemia

50. Severe Wound Healing Impairment in a Patient with Dysfibrinogenaemia

Catalog

Books, media, physical & digital resources